世界の血漿プロテアーゼC1阻害剤治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Plasma Protease C1-inhibitor Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4640 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、血漿プロテアーゼC1阻害剤治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（C1阻害剤、カリクレイン阻害剤（カルビトール））、用途別市場規模（病院薬局、独立型薬局＆アウトレット）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・血漿プロテアーゼC1阻害剤治療の市場動向 ・企業の競争状況、市場シェア ・血漿プロテアーゼC1阻害剤治療の種類別市場規模（C1阻害剤、カリクレイン阻害剤（カルビトール）） ・血漿プロテアーゼC1阻害剤治療の用途別市場規模（病院薬局、独立型薬局＆アウトレット） ・血漿プロテアーゼC1阻害剤治療の北米市場規模2016-2027（アメリカ、カナダ） ・血漿プロテアーゼC1阻害剤治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・血漿プロテアーゼC1阻害剤治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・血漿プロテアーゼC1阻害剤治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・血漿プロテアーゼC1阻害剤治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Takeda、CSL Limited、Sanquin、Pharming Group N.V.） ・結論

This report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rare diseases around the world, promising pipeline drugs and novel therapies, rising investments in innovation of inhibitor drugs and increasing HAE awareness programs are the major drivers of the global plasma protease C1-inhibitors treatment market.
Based on drug class, the market has been segmented into C1-inhibitors (C1-esterase Inhibitor, Recombinant Inhibitor); Kallikrein Inhibitor (Kalbitor); Selective Bradykinin B2 Receptor Antagonist (Firazyr). The drug class market segments have been analyzed based on available approved products, cost-effectiveness, and preference given by the physicians for the treatment of HAE patients.

Market Analysis and Insights: Global Plasma Protease C1-inhibitor Treatment Market
The global Plasma Protease C1-inhibitor Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Plasma Protease C1-inhibitor Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Plasma Protease C1-inhibitor Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Plasma Protease C1-inhibitor Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Plasma Protease C1-inhibitor Treatment market.

Global Plasma Protease C1-inhibitor Treatment Scope and Market Size
Plasma Protease C1-inhibitor Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Plasma Protease C1-inhibitor Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
C1-inhibitors
Kallikrein Inhibitor (Kalbitor)

Segment by Application
Hospital Pharmacies
Independent Pharmacies and Outlets

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Takeda
CSL Limited
Sanquin

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 C1-inhibitors
1.2.3 Kallikrein Inhibitor (Kalbitor)
1.3 Market by Application
1.3.1 Global Plasma Protease C1-inhibitor Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Independent Pharmacies and Outlets
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Plasma Protease C1-inhibitor Treatment Market Perspective (2016-2027)
2.2 Plasma Protease C1-inhibitor Treatment Growth Trends by Regions
2.2.1 Plasma Protease C1-inhibitor Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Plasma Protease C1-inhibitor Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Plasma Protease C1-inhibitor Treatment Industry Dynamic
2.3.1 Plasma Protease C1-inhibitor Treatment Market Trends
2.3.2 Plasma Protease C1-inhibitor Treatment Market Drivers
2.3.3 Plasma Protease C1-inhibitor Treatment Market Challenges
2.3.4 Plasma Protease C1-inhibitor Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Plasma Protease C1-inhibitor Treatment Players by Revenue
3.1.1 Global Top Plasma Protease C1-inhibitor Treatment Players by Revenue (2016-2021)
3.1.2 Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Plasma Protease C1-inhibitor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Plasma Protease C1-inhibitor Treatment Revenue
3.4 Global Plasma Protease C1-inhibitor Treatment Market Concentration Ratio
3.4.1 Global Plasma Protease C1-inhibitor Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasma Protease C1-inhibitor Treatment Revenue in 2020
3.5 Plasma Protease C1-inhibitor Treatment Key Players Head office and Area Served
3.6 Key Players Plasma Protease C1-inhibitor Treatment Product Solution and Service
3.7 Date of Enter into Plasma Protease C1-inhibitor Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Plasma Protease C1-inhibitor Treatment Breakdown Data by Type
4.1 Global Plasma Protease C1-inhibitor Treatment Historic Market Size by Type (2016-2021)
4.2 Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Type (2022-2027)

5 Plasma Protease C1-inhibitor Treatment Breakdown Data by Application
5.1 Global Plasma Protease C1-inhibitor Treatment Historic Market Size by Application (2016-2021)
5.2 Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Plasma Protease C1-inhibitor Treatment Market Size (2016-2027)
6.2 North America Plasma Protease C1-inhibitor Treatment Market Size by Type
6.2.1 North America Plasma Protease C1-inhibitor Treatment Market Size by Type (2016-2021)
6.2.2 North America Plasma Protease C1-inhibitor Treatment Market Size by Type (2022-2027)
6.2.3 North America Plasma Protease C1-inhibitor Treatment Market Size by Type (2016-2027)
6.3 North America Plasma Protease C1-inhibitor Treatment Market Size by Application
6.3.1 North America Plasma Protease C1-inhibitor Treatment Market Size by Application (2016-2021)
6.3.2 North America Plasma Protease C1-inhibitor Treatment Market Size by Application (2022-2027)
6.3.3 North America Plasma Protease C1-inhibitor Treatment Market Size by Application (2016-2027)
6.4 North America Plasma Protease C1-inhibitor Treatment Market Size by Country
6.4.1 North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2016-2021)
6.4.2 North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Plasma Protease C1-inhibitor Treatment Market Size (2016-2027)
7.2 Europe Plasma Protease C1-inhibitor Treatment Market Size by Type
7.2.1 Europe Plasma Protease C1-inhibitor Treatment Market Size by Type (2016-2021)
7.2.2 Europe Plasma Protease C1-inhibitor Treatment Market Size by Type (2022-2027)
7.2.3 Europe Plasma Protease C1-inhibitor Treatment Market Size by Type (2016-2027)
7.3 Europe Plasma Protease C1-inhibitor Treatment Market Size by Application
7.3.1 Europe Plasma Protease C1-inhibitor Treatment Market Size by Application (2016-2021)
7.3.2 Europe Plasma Protease C1-inhibitor Treatment Market Size by Application (2022-2027)
7.3.3 Europe Plasma Protease C1-inhibitor Treatment Market Size by Application (2016-2027)
7.4 Europe Plasma Protease C1-inhibitor Treatment Market Size by Country
7.4.1 Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2016-2021)
7.4.2 Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size (2016-2027)
8.2 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Type
8.2.1 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Application
8.3.1 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region
8.4.1 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Plasma Protease C1-inhibitor Treatment Market Size (2016-2027)
9.2 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Type
9.2.1 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Type (2016-2027)
9.3 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Application
9.3.1 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Application (2016-2027)
9.4 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country
9.4.1 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size (2016-2027)
10.2 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Type
10.2.1 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Application
10.3.1 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country
10.4.1 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Plasma Protease C1-inhibitor Treatment Introduction
11.1.4 Takeda Revenue in Plasma Protease C1-inhibitor Treatment Business (2016-2021)
11.1.5 Takeda Recent Development
11.2 CSL Limited
11.2.1 CSL Limited Company Details
11.2.2 CSL Limited Business Overview
11.2.3 CSL Limited Plasma Protease C1-inhibitor Treatment Introduction
11.2.4 CSL Limited Revenue in Plasma Protease C1-inhibitor Treatment Business (2016-2021)
11.2.5 CSL Limited Recent Development
11.3 Sanquin
11.3.1 Sanquin Company Details
11.3.2 Sanquin Business Overview
11.3.3 Sanquin Plasma Protease C1-inhibitor Treatment Introduction
11.3.4 Sanquin Revenue in Plasma Protease C1-inhibitor Treatment Business (2016-2021)
11.3.5 Sanquin Recent Development
11.4 Pharming Group N.V.
11.4.1 Pharming Group N.V. Company Details
11.4.2 Pharming Group N.V. Business Overview
11.4.3 Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Introduction
11.4.4 Pharming Group N.V. Revenue in Plasma Protease C1-inhibitor Treatment Business (2016-2021)
11.4.5 Pharming Group N.V. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of C1-inhibitors
Table 3. Key Players of Kallikrein Inhibitor (Kalbitor)
Table 4. Global Plasma Protease C1-inhibitor Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Plasma Protease C1-inhibitor Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Plasma Protease C1-inhibitor Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Plasma Protease C1-inhibitor Treatment Market Share by Regions (2016-2021)
Table 8. Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Plasma Protease C1-inhibitor Treatment Market Share by Regions (2022-2027)
Table 10. Plasma Protease C1-inhibitor Treatment Market Trends
Table 11. Plasma Protease C1-inhibitor Treatment Market Drivers
Table 12. Plasma Protease C1-inhibitor Treatment Market Challenges
Table 13. Plasma Protease C1-inhibitor Treatment Market Restraints
Table 14. Global Plasma Protease C1-inhibitor Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Plasma Protease C1-inhibitor Treatment Market Share by Players (2016-2021)
Table 16. Global Top Plasma Protease C1-inhibitor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasma Protease C1-inhibitor Treatment as of 2020)
Table 17. Ranking of Global Top Plasma Protease C1-inhibitor Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Plasma Protease C1-inhibitor Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Plasma Protease C1-inhibitor Treatment Product Solution and Service
Table 21. Date of Enter into Plasma Protease C1-inhibitor Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Plasma Protease C1-inhibitor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Plasma Protease C1-inhibitor Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Plasma Protease C1-inhibitor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Plasma Protease C1-inhibitor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Plasma Protease C1-inhibitor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Plasma Protease C1-inhibitor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Plasma Protease C1-inhibitor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Plasma Protease C1-inhibitor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Plasma Protease C1-inhibitor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Plasma Protease C1-inhibitor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Plasma Protease C1-inhibitor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Plasma Protease C1-inhibitor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Plasma Protease C1-inhibitor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Plasma Protease C1-inhibitor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Takeda Company Details
Table 62. Takeda Business Overview
Table 63. Takeda Plasma Protease C1-inhibitor Treatment Product
Table 64. Takeda Revenue in Plasma Protease C1-inhibitor Treatment Business (2016-2021) & (US$ Million)
Table 65. Takeda Recent Development
Table 66. CSL Limited Company Details
Table 67. CSL Limited Business Overview
Table 68. CSL Limited Plasma Protease C1-inhibitor Treatment Product
Table 69. CSL Limited Revenue in Plasma Protease C1-inhibitor Treatment Business (2016-2021) & (US$ Million)
Table 70. CSL Limited Recent Development
Table 71. Sanquin Company Details
Table 72. Sanquin Business Overview
Table 73. Sanquin Plasma Protease C1-inhibitor Treatment Product
Table 74. Sanquin Revenue in Plasma Protease C1-inhibitor Treatment Business (2016-2021) & (US$ Million)
Table 75. Sanquin Recent Development
Table 76. Pharming Group N.V. Company Details
Table 77. Pharming Group N.V. Business Overview
Table 78. Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Product
Table 79. Pharming Group N.V. Revenue in Plasma Protease C1-inhibitor Treatment Business (2016-2021) & (US$ Million)
Table 80. Pharming Group N.V. Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasma Protease C1-inhibitor Treatment Market Share by Type: 2020 VS 2027
Figure 2. C1-inhibitors Features
Figure 3. Kallikrein Inhibitor (Kalbitor) Features
Figure 4. Global Plasma Protease C1-inhibitor Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Independent Pharmacies and Outlets Case Studies
Figure 7. Plasma Protease C1-inhibitor Treatment Report Years Considered
Figure 8. Global Plasma Protease C1-inhibitor Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Plasma Protease C1-inhibitor Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Plasma Protease C1-inhibitor Treatment Market Share by Regions: 2020 VS 2027
Figure 11. Global Plasma Protease C1-inhibitor Treatment Market Share by Regions (2022-2027)
Figure 12. Global Plasma Protease C1-inhibitor Treatment Market Share by Players in 2020
Figure 13. Global Top Plasma Protease C1-inhibitor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasma Protease C1-inhibitor Treatment as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Plasma Protease C1-inhibitor Treatment Revenue in 2020
Figure 15. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Type (2016-2021)
Figure 16. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Type (2022-2027)
Figure 17. North America Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Plasma Protease C1-inhibitor Treatment Market Share by Type (2016-2027)
Figure 19. North America Plasma Protease C1-inhibitor Treatment Market Share by Application (2016-2027)
Figure 20. North America Plasma Protease C1-inhibitor Treatment Market Share by Country (2016-2027)
Figure 21. United States Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Plasma Protease C1-inhibitor Treatment Market Share by Type (2016-2027)
Figure 25. Europe Plasma Protease C1-inhibitor Treatment Market Share by Application (2016-2027)
Figure 26. Europe Plasma Protease C1-inhibitor Treatment Market Share by Country (2016-2027)
Figure 27. Germany Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Share by Region (2016-2027)
Figure 37. China Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Plasma Protease C1-inhibitor Treatment Market Share by Type (2016-2027)
Figure 45. Latin America Plasma Protease C1-inhibitor Treatment Market Share by Application (2016-2027)
Figure 46. Latin America Plasma Protease C1-inhibitor Treatment Market Share by Country (2016-2027)
Figure 47. Mexico Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Share by Country (2016-2027)
Figure 53. Turkey Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Takeda Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2016-2021)
Figure 57. CSL Limited Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2016-2021)
Figure 58. Sanquin Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2016-2021)
Figure 59. Pharming Group N.V. Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2016-2021)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

---